Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents

Bart, Aaron G.; Morais, Goreti; Vangala, Venu R.; Loadman, Paul M.; Pors, Klaus; Scott, Emily E.

doi:10.1124/dmd.121.000642

Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents

Journal Article · 04 October 2021 · Drug Metabolism and Disposition

DOI:https://doi.org/10.1124/dmd.121.000642· OSTI ID:1982942

Bart, Aaron G.; Morais, Goreti; Vangala, Venu R.; Loadman, Paul M.; Pors, Klaus; Scott, Emily E.

Not provided.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: USDOE

DOE Contract Number:: AC02-06CH11357

OSTI ID:: 1982942

Journal Information:: Drug Metabolism and Disposition, Vol. 50, Issue 1; ISSN 0090-9556

Publisher:: American Society for Pharmacology and Experimental Therapeutics (ASPET)

Country of Publication:: United States

Language:: English

References (43)

PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes Bart, Aaron G.; Scott, Emily E. Journal of Biological Chemistry, Vol. 292, Issue 51 https://doi.org/10.1074/jbc.RA117.000220	journal	December 2017
Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands Bart, Aaron G.; Scott, Emily E. Journal of Biological Chemistry, Vol. 293, Issue 50 https://doi.org/10.1074/jbc.RA118.005588	journal	September 2018
Human Cytochrome P450 1A1 Adapts Active Site for Atypical Nonplanar Substrate Bart, Aaron G.; Takahashi, Ryan H.; Wang, Xiaojing Drug Metabolism and Disposition, Vol. 48, Issue 2 https://doi.org/10.1124/dmd.119.089607	journal	November 2019
Developmental Regulation and Induction of Cytochrome P450 2W1, an Enzyme Expressed in Colon Tumors Choong, Eva; Guo, Jia; Persson, Anna PLOS ONE, Vol. 10, Issue 4 https://doi.org/10.1371/journal.pone.0122820	journal	April 2015
Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes DeVore, N. M.; Smith, B. D.; Wang, J. L. Drug Metabolism and Disposition, Vol. 37, Issue 6 https://doi.org/10.1124/dmd.109.026765	journal	February 2009
OLEX2 : a complete structure solution, refinement and analysis program Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J. Journal of Applied Crystallography, Vol. 42, Issue 2 https://doi.org/10.1107/S0021889808042726	journal	January 2009
The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer – A pilot study Edler, David; Stenstedt, Kristina; Öhrling, Katarina European Journal of Cancer, Vol. 45, Issue 4 https://doi.org/10.1016/j.ejca.2008.11.031	journal	March 2009
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
How good are my data and what is the resolution? Evans, Philip R.; Murshudov, Garib N. Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7 https://doi.org/10.1107/S0907444913000061	journal	June 2013
Expression of CYP2W1 in colon tumors: regulation by gene methylation Gomez, Alvin; Karlgren, Maria; Edler, David Pharmacogenomics, Vol. 8, Issue 10 https://doi.org/10.2217/14622416.8.10.1315	journal	October 2007
Colorectal Cancer-Specific Cytochrome P450 2W1: Intracellular Localization, Glycosylation, and Catalytic Activity Gomez, Alvin; Nekvindova, Jana; Travica, Sandra Molecular Pharmacology, Vol. 78, Issue 6 https://doi.org/10.1124/mol.110.067652	journal	August 2010
Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1 Guo, Jia; Thiess, Stefanie; Johansson, Inger FEBS Letters, Vol. 590, Issue 3 https://doi.org/10.1002/1873-3468.12063	journal	February 2016
How can the potential of the duocarmycins be unlocked for cancer therapy? Jukes, Zoë; Morais, Goreti Ribeiro; Loadman, Paul M. Drug Discovery Today, Vol. 26, Issue 2 https://doi.org/10.1016/j.drudis.2020.11.020	journal	February 2021
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1 Karlgren, Maria; Gomez, Alvin; Stark, Katarina Biochemical and Biophysical Research Communications, Vol. 341, Issue 2 https://doi.org/10.1016/j.bbrc.2005.12.200	journal	March 2006
Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapy Karlgren, Maria; Ingelman-Sundberg, Magnus Expert Opinion on Therapeutic Targets, Vol. 11, Issue 1 https://doi.org/10.1517/14728222.11.1.61	journal	December 2006
Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans Lang, Dieter; Radtke, Martin; Bairlein, Michaela Chemical Research in Toxicology, Vol. 32, Issue 6 https://doi.org/10.1021/acs.chemrestox.8b00413	journal	April 2019
Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures Macrae, Clare F.; Bruno, Ian J.; Chisholm, James A. Journal of Applied Crystallography, Vol. 41, Issue 2 https://doi.org/10.1107/S0021889807067908	journal	March 2008
Identification of Human Cytochrome P450s Involved in the Formation of All-trans-Retinoic Acid Principal Metabolites Marill, Julie; Cresteil, Thierry; Lanotte, Michel Molecular Pharmacology, Vol. 58, Issue 6 https://doi.org/10.1124/mol.58.6.1341	journal	December 2000
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Acta Crystallographica Section D Biological Crystallography, Vol. 65, Issue 10 https://doi.org/10.1107/S0907444909029436	journal	September 2009
Efficient Hypoxic Activation of the Anticancer Agent AQ4N by CYP2S1 and CYP2W1 Nishida, Clinton R.; Lee, Melody; de Montellano, Paul R. Ortiz Molecular Pharmacology, Vol. 78, Issue 3 https://doi.org/10.1124/mol.110.065045	journal	June 2010
The Carbon Monoxide-binding Pigment of Liver Microsomes Omura, Tsuneo; Sato, Ryo Journal of Biological Chemistry, Vol. 239, Issue 7 https://doi.org/10.1016/S0021-9258(20)82244-3	journal	July 1964
NMRPipe: A multidimensional spectral processing system based on UNIX pipes Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW. Journal of Biomolecular NMR, Vol. 6, Issue 3 https://doi.org/10.1007/BF00197809	journal	November 1995
Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity Pors, Klaus; Loadman, Paul M.; Shnyder, Steven D. Chemical Communications, Vol. 47, Issue 44 https://doi.org/10.1039/c1cc15638a	journal	January 2011
High-Yield Expression of a Catalytically Active Membrane-Bound Protein: Human P450 Oxidoreductase Sandee, Duanpen; Miller, Walter L. Endocrinology, Vol. 152, Issue 7 https://doi.org/10.1210/en.2011-0230	journal	May 2011
Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2 Sansen, Stefaan; Yano, Jason K.; Reynald, Rosamund L. Journal of Biological Chemistry, Vol. 282, Issue 19 https://doi.org/10.1074/jbc.M611692200	journal	February 2007
Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity Sheldrake, Helen M.; Travica, Sandra; Johansson, Inger Journal of Medicinal Chemistry, Vol. 56, Issue 15 https://doi.org/10.1021/jm4000209	journal	July 2013
A short history of SHELX Sheldrick, George M. Acta Crystallographica Section A Foundations of Crystallography, Vol. 64, Issue 1, p. 112-122 https://doi.org/10.1107/S0108767307043930	journal	December 2007
SHELXT – Integrated space-group and crystal-structure determination Sheldrick, George M. Acta Crystallographica Section A Foundations and Advances, Vol. 71, Issue 1, p. 3-8 https://doi.org/10.1107/S2053273314026370	journal	January 2015
Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies Sneha, Smarakan; Baker, Simon C.; Green, Andrew Biomedicines, Vol. 9, Issue 3 https://doi.org/10.3390/biomedicines9030290	journal	March 2021
The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases Stenstedt, Kristina; Hallstrom, Marja; Lédel, Frida Acta Oncologica, Vol. 53, Issue 7 https://doi.org/10.3109/0284186X.2014.887224	journal	March 2014
Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder Sutherland, Mark; Gill, Jason H.; Loadman, Paul M. Molecular Cancer Therapeutics, Vol. 12, Issue 1 https://doi.org/10.1158/1535-7163.MCT-12-0405	journal	January 2013
Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins Travica, Sandra; Pors, Klaus; Loadman, Paul M. Clinical Cancer Research, Vol. 19, Issue 11 https://doi.org/10.1158/1078-0432.CCR-13-0238	journal	May 2013
MOLREP an Automated Program for Molecular Replacement Vagin, A.; Teplyakov, A. Journal of Applied Crystallography, Vol. 30, Issue 6, p. 1022-1025 https://doi.org/10.1107/S0021889897006766	journal	December 1997
Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism Walsh, Agnes A.; Szklarz, Grazyna D.; Scott, Emily E. Journal of Biological Chemistry, Vol. 288, Issue 18 https://doi.org/10.1074/jbc.M113.452953	journal	March 2013
Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1 Wang, An; Savas, Uzen; Stout, C. David Journal of Biological Chemistry, Vol. 286, Issue 7 https://doi.org/10.1074/jbc.M110.204420	journal	December 2010
Bioactivation of Fluorinated 2-Aryl-benzothiazole Antitumor Molecules by Human Cytochrome P450s 1A1 and 2W1 and Deactivation by Cytochrome P450 2S1 Wang, Kai; Guengerich, F. Peter Chemical Research in Toxicology, Vol. 25, Issue 8 https://doi.org/10.1021/tx3001994	journal	July 2012
Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1 Wu, Zhong-Liu; Sohl, Christal D.; Shimada, Tsutomu Molecular Pharmacology, Vol. 69, Issue 6 https://doi.org/10.1124/mol.106.023648	journal	March 2006
Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids Xiao, Yi; Guengerich, F. Peter Journal of Lipid Research, Vol. 53, Issue 8 https://doi.org/10.1194/jlr.M027185	journal	August 2012
Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N Yakkundi, A.; McErlane, V.; Murray, M. Cancer Gene Therapy, Vol. 13, Issue 6 https://doi.org/10.1038/sj.cgt.7700933	journal	January 2006
Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates Zhao, Y.; Wan, D.; Yang, J. Drug Metabolism and Disposition, Vol. 44, Issue 5 https://doi.org/10.1124/dmd.116.069633	journal	March 2016

Similar Records

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse

Journal Article · 2008 · Toxicology and Applied Pharmacology · OSTI ID:21077912

Stiborova, Marie; Arlt, Volker M; Henderson, Colin J; +6 more

Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450_BM3 Variants

Journal Article · 2016 · Biochemistry · OSTI ID:1260843

Geronimo, Inacrist; Denning, Catherine A.; Rogers, W. Eric; +5 more

Human cytochrome P450 17A1 structures with metabolites of prostate cancer drug abiraterone reveal substrate-binding plasticity and a second binding site

Journal Article · 2023 · Journal of Biological Chemistry · OSTI ID:2471704

Petrunak, Elyse M.; Bart, Aaron G.; Peng, Hwei-Ming; +2 more

Related Subjects

Pharmacology & Pharmacy

Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents

Citation Formats

References (43)

Similar Records

Related Subjects